Total Payments
$49,924
2024 Payments
$14,545
Companies
15
Transactions
63
Medicare Patients
784
Medicare Billing
$151,995
Payment Breakdown by Category
Consulting$37,730 (75.6%)
Travel$5,408 (10.8%)
Other$5,043 (10.1%)
Food & Beverage$1,723 (3.5%)
Education$20.21 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $37,730 | 17 | 75.6% |
| Travel and Lodging | $5,408 | 15 | 10.8% |
| Honoraria | $4,900 | 1 | 9.8% |
| Food and Beverage | $1,723 | 27 | 3.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $74.21 | 1 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $68.61 | 1 | 0.1% |
| Education | $20.21 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14,179 | 9 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $11,665 | 15 | $0 (2024) |
| Novocure Inc. | $6,376 | 13 | $0 (2024) |
| Daiichi Sankyo Inc. | $4,232 | 5 | $0 (2023) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $4,063 | 3 | $0 (2023) |
| Regeneron Pharmaceuticals, Inc. | $3,434 | 8 | $0 (2024) |
| Amgen Inc. | $3,245 | 2 | $0 (2022) |
| Merck Sharp & Dohme LLC | $2,440 | 1 | $0 (2023) |
| Ethicon US, LLC | $124.50 | 1 | $0 (2022) |
| AstraZeneca UK Limited | $49.99 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,545 | 16 | AstraZeneca Pharmaceuticals LP ($6,453) |
| 2023 | $15,798 | 31 | E.R. Squibb & Sons, L.L.C. ($6,065) |
| 2022 | $8,772 | 9 | E.R. Squibb & Sons, L.L.C. ($3,344) |
| 2021 | $10,781 | 5 | E.R. Squibb & Sons, L.L.C. ($4,770) |
| 2019 | $27.42 | 2 | EISAI INC. ($14.22) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/05/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,497.50 | General |
| 03/06/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $13.99 | General |
| Category: Oncology | ||||||
| 03/01/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $2,775.00 | General |
| Category: Oncology | ||||||
| 02/23/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $2,352.00 | General |
| Category: ONCOLOGY | ||||||
| 02/23/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $296.95 | General |
| Category: ONCOLOGY | ||||||
| 02/23/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $286.90 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2024 | Novocure Inc. | Optune Lua (NovoTTF-200T) (Device) | Food and Beverage | Cash or cash equivalent | $101.73 | General |
| Category: Oncology | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Travel and Lodging | In-kind items and services | $598.78 | General |
| Category: Oncology | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Travel and Lodging | In-kind items and services | $332.32 | General |
| Category: Oncology | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $80.18 | General |
| Category: Oncology | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $52.39 | General |
| Category: Oncology | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $49.25 | General |
| Category: Oncology | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $45.26 | General |
| Category: Oncology | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Oncology | ||||||
| 01/11/2024 | Novocure Inc. | Optune Lua (NovoTTF-200T) (Device) | Honoraria | Cash or cash equivalent | $4,900.00 | General |
| Category: Oncology | ||||||
| 01/11/2024 | Novocure Inc. | Optune Lua (NovoTTF-200T) (Device) | Travel and Lodging | Cash or cash equivalent | $140.95 | General |
| Category: Oncology | ||||||
| 12/22/2023 | Novocure Inc. | — | Food and Beverage | Cash or cash equivalent | $42.92 | General |
| 12/22/2023 | Novocure Inc. | — | Food and Beverage | Cash or cash equivalent | $30.82 | General |
| 12/20/2023 | Daiichi Sankyo Inc. | — | Consulting Fee | Cash or cash equivalent | $1,665.00 | General |
| 12/15/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $147.06 | General |
| Category: ONCOLOGY | ||||||
| 12/15/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $85.80 | General |
| Category: ONCOLOGY | ||||||
| 12/15/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $62.03 | General |
| Category: ONCOLOGY | ||||||
| 12/15/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: ONCOLOGY | ||||||
| 12/14/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $174.93 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $2,440.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 151 | 256 | $55,368 | $24,837 |
| 2022 | 5 | 199 | 377 | $80,062 | $35,246 |
| 2021 | 6 | 216 | 551 | $118,058 | $54,525 |
| 2020 | 8 | 218 | 453 | $100,086 | $37,387 |
Total Patients
784
Total Services
1,637
Medicare Billing
$151,995
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 83 | $19,754 | $9,027 | 45.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 41 | 71 | $16,898 | $7,543 | 44.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 29 | 55 | $8,690 | $3,971 | 45.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 34 | $5,372 | $2,593 | 48.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 13 | 13 | $4,654 | $1,703 | 36.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 47 | 112 | $26,656 | $12,185 | 45.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 28 | 54 | $12,852 | $5,907 | 46.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 63 | $9,954 | $4,645 | 46.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 36 | $7,704 | $2,783 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 21 | 37 | $5,846 | $2,687 | 46.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 23 | 35 | $5,530 | $2,529 | 45.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $5,370 | $2,011 | 37.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $3,938 | $1,576 | 40.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 11 | 14 | $2,212 | $924.17 | 41.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 45 | 165 | $39,270 | $18,209 | 46.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 39 | 118 | $28,084 | $13,489 | 48.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 86 | $13,588 | $6,538 | 48.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 30 | 69 | $10,902 | $5,318 | 48.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 23 | 46 | $7,268 | $3,543 | 48.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 39 | $8,346 | $3,159 | 37.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 16 | $6,304 | $2,513 | 39.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $4,296 | $1,757 | 40.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 38 | 131 | $31,178 | $11,505 | 36.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 29 | 88 | $20,944 | $7,697 | 36.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 32 | 83 | $13,114 | $5,035 | 38.4% |
About Dr. Debora Bruno, M.D
Dr. Debora Bruno, M.D is a Hematology & Oncology healthcare provider based in Hastings, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437100302.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Debora Bruno, M.D has received a total of $49,924 in payments from pharmaceutical and medical device companies, with $14,545 received in 2024. These payments were reported across 63 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($37,730).
As a Medicare-enrolled provider, Bruno has provided services to 784 Medicare beneficiaries, totaling 1,637 services with total Medicare billing of $151,995. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Hastings, NE
- Active Since 05/15/2006
- Last Updated 09/17/2008
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1437100302
Products in Payments
- OPDIVO (Biological) $8,435
- TAGRISSO (Drug) $5,898
- Optune Lua (NovoTTF-200T) (Device) $5,143
- LIBTAYO (Biological) $3,434
- IMFINZI (Biological) $2,355
- TABRECTA (Drug) $1,965
- Echelon Flex (Device) $124.50
- ZEPZELCA (Drug) $20.21
- Stivarga (Drug) $20.01
- Halaven (Drug) $14.22
- KRAZATI (Drug) $13.99
- LYNPARZA (Drug) $13.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.